ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to have a visual discussion about all of the possible outcomes of breast augmentation. Our revolutionary artistic platform gives the surgeon the perfect opportunity to create the ideal size and shape for every possible situation. The best part is that now the surgeon and patient will share the same visual expectation of surgery, and equally important, have a mutual understanding of the limitations of surgery based on the patients unique anatomy. Remember, ILLUSIO is primarily an artistic tool created to manage patient expectations. With ILLUSIO, the overall time per consult could become shorter and patients could make decisions quicker and with much more confidence. Above all, they will have fun with the process. The ability to look into our Virtual Mirror and see themselves with their virtual breasts is new and exciting and provides a real Wow experience. As patients become engaged in the process they will very likely want to share their ILLUSIO experience with their friends and family. Source
No articles found.
Vertex is a global biotechnology company that invests in scientific innovation to ...
Vertex is a global biotechnology company that i...
Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical...
Neurocrine Biosciences (Nasdaq: NBIX) is a neur...
For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...
For more than 40 years, IntriCon has been meeti...
INmune Bio Inc. is a clinical stage biotechnology company that is developing new i...
INmune Bio Inc. is a clinical stage biotechnolo...
Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-i...
Aerpio Pharmaceuticals is a biopharmaceutical c...
Fresenius is a global healthcare group offering high-quality products and services...
Fresenius is a global healthcare group offering...
We develop and deliver the industry's only end-to-end portfolio of network equipme...
We develop and deliver the industry's only end-...
Join the National Investor Network and get the latest information with your interests in mind.